Interim guidance on the eosinophilia-myalgia syndrome

Ann Intern Med. 1990 Jan 15;112(2):85-7. doi: 10.7326/0003-4819-112-2-85.
No abstract available

MeSH terms

  • Centers for Disease Control and Prevention, U.S.
  • Eosinophilia / chemically induced*
  • Eosinophilia / diagnosis
  • Eosinophilia / therapy
  • Fatigue / chemically induced
  • Humans
  • Muscular Diseases / chemically induced*
  • Muscular Diseases / diagnosis
  • Muscular Diseases / therapy
  • Pain / chemically induced
  • Syndrome
  • Tryptophan / adverse effects*
  • United States

Substances

  • Tryptophan